When was Molecule.one founded?

Molecule.one was founded in 2016 and raised its 1st funding round 3 years after it was founded.

Where is Molecule.one located?

Molecule.one is headquartered in Warsaw, Poland.

Who is the current CEO of Molecule.one?

Piotr Byrski of Molecule.one. They have also founded 1 company.

How many employees does Molecule.one have?

As of Aug 31, 2026, the latest employee count at Molecule.one is 37.

Is Molecule.one a funded company?

Molecule.one is a funded company, having raised a total of $4.63M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Aug 27, 2019.

When was the latest funding round of Molecule.one?

Molecule.one's latest funding was a $***** Seed round on May 04, 2021, with participation from 8 investors. Its primary sector is Life Sciences Tech. In Poland, the Life Sciences Tech sector has seen $15.1M in funding in 2026 to date.

What is the annual revenue of Molecule.one?

Annual revenue of Molecule.one is less than $1M as on Dec 31, 2024

Where does Molecule.one rank among its competitors?

Molecule.one ranks 18th amongst 248 active competitors, of which 60 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Cartography Biosciences, which secured an undisclosed amount in May, 2026.

Who are the top competitors of Molecule.one?

Molecule.one's top competitors include Citrine Informatics, Certara and Cartography Biosciences. Among them, Cartography Biosciences secured the most recent funding round in May, 2026.

Molecule.one - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Provider of AI-based software research for molecule drug designing and synthesis. The technology enables users to pick search criteria and proposes relevant reactions, scores them, and assembles them into full synthesis pathways for molecule synthesis.

Website: molecule.one
Social
Email ID: *****@molecule.one

Key Metrics

Founded Year

2016

Location

Warsaw, Poland

Stage

Seed

Total Funding

$4.63M in 2 rounds

Latest Funding Round

Seed, May 04, 2021, $*****

Investors

Sunfish Partners & 11 more

Ranked

18^th among 248 active competitors

Annual Revenue

$0 - $1M as on Dec 31, 2024

Employee Count

37 as on Aug 31, 2026

Similar Companies

Citrine Informatics & 273 more

View Molecule.one's full profile

Molecule.one is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MOLECULE ONE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ CIN: 0000649610 , Poland, Active	Nov 29, 2016	-	-
Molecule One sp. z o.o CIN: 649610 , Poland, Active	Nov 28, 2016	$0 - $1M (As on Dec 31, 2024)	-

Molecule.one has raised a total funding of $4.63M over 2 rounds. Its first funding round was on Aug 27, 2019. Its latest funding round was a Seed round on May 04, 2021 for $*****. 8 investors participated in its latest round. Molecule.one has 11 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Molecule.one:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 04, 2021	8772613	Seed	4800902	9472555	6302826	3025363
Aug 27, 2019	2128052	Seed	1278956	8158990	Sunfish Partners	8902869

Access funding benchmarks and valuations. Sign up today!

View details of Molecule.one's funding rounds and investors

The founders of Molecule.one are Piotr Byrski and Pawel Laskarzewski. Piotr Byrski is the CEO of Molecule.one.

Here are the details of Molecule.one's key team members:

Piotr Byrski: Co-Founder & CEO of Molecule.one.
Contact Info: 1 email address
Pawel Laskarzewski: Co-Founder & COO of Molecule.one.
Contact Info: 1 email address

View details of Molecule.one's Founder profiles and Board Members

Molecule.one's employee count trend

Molecule.one has 37 employees as of Aug 26. Here is Molecule.one's employee count trend over the years:

Uncover Molecule.one's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Molecule.one include Citrine Informatics, Certara and Cartography Biosciences. Here is the list of Top 10 competitors of Molecule.one, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Citrine Informatics 2013, Redwood City (United States), Series C	Provider of AI-based solutions for materials informatics	$81.3M	Innovation Endeavors, Prelude Ventures & 17 others	70/100
2nd	Certara 2008, Princeton (United States), Public	Provider of a platform for in silico drug discovery and consulting services	-	HTIF, Mubadala & 3 others	65/100
3rd	Cartography Biosciences 2020, Foster City (United States), Series B	Provider of a platform to discover immunotherapeutics	$124M	Pfizer, 8VC & 19 others	63/100
4th	Astex Pharmaceuticals 1991, Pleasanton (United States), Acquired	Oncology and CNS drug discovery and development using cutting-edge technology	$3M	New Enterprise Associates, Saints Capital ... & 6 others	60/100
5th	Polymerize IO 2020, Singapore (Singapore), Series A	AI platform for material property prediction and design	$4.65M	Elevation Capital, Info Edge Ventures & 1 others	60/100
6th	Pharmacelera 2015, Barcelona (Spain), Series A	Hardware and software solutions for computer-aided drug design	$7.1M	HERAN Partners, The Collider & 6 others	59/100
7th	Oxford Drug Design 2001, Oxford (United Kingdom), Series A	Provider of computer-aided design of antibiotics for MDR infections	$12.4M	o2h ventures, R42 Group & 55 others	59/100
8th	Enzymit 2020, Ness Ziona (Israel), Series A	Developer of novel enzymes and cell-free bioproduction platforms for diverse markets	$15M	Grove Ventures, Khosla Ventures & 5 others	58/100
9th	Inpharmatica 1998, London (United Kingdom), Acquired	Developer of predictive informatics based platform for drug discovery	$75M	Vertex Ventures, Advent Life Sciences & 6 others	58/100
10th	Genialis 2015, Boston (United States), Series A	Developer of end-to-end bioinformatics software solutions	$16M	Taiwania Capital, Debiopharm & 9 others	56/100
18th	Molecule.one 2016, Warsaw (Poland), Seed	Provider of AI-based software research for molecule drug designing and synthesis	$4.63M	AME Cloud Ventures, Inventures & 10 others	46/100